LM
ACET icon

Luminus Management’s Adicet Bio ACET Stock Holding History

Luminus Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-59,558
Closed -$501K – 25
2025
Q4 		$501K Buy
+59,558
New +$658K 0.44% 14
2025
Q3 		– Sell
-18,121
Closed -$177K – 20
2025
Q2 		$177K Buy
+18,121
New +$191K 0.05% 19

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Luminus Management's ACET Position: Q1 2026 in Review

Luminus Management sold out of Adicet Bio (ACET) in Q1 2026, closing a stake of 59,558 shares — an estimated $501K sold.

Luminus Management first reported a position in ACET in Q2 2025 and held it in 2 quarters. The position peaked at $501K in Q4 2025. 49 funds tracked by Wall St. Rank hold ACET as of Q1 2026.

  • Luminus Management reported no remaining Adicet Bio position as of Q1 2026 after selling out during the quarter.
  • Luminus Management sold 59,558 Adicet Bio shares in Q1 2026, an estimated $501K.
  • Luminus Management first reported a position in Adicet Bio in Q2 2025 and held it in 2 quarters.
  • Luminus Management's Adicet Bio position peaked at $501K in Q4 2025.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2026.

Based on Luminus Management's 13F filing for Q1 2026, filed 15 May 2026.